A: Postcontrast axial CT of the neck shows the small, localized, space-occupying lesion (arrow) in the subglotti c area on the left without evidence of lymphadenopathy. B: Fourteen months later; Tl -weighted postcontrast coronal MRI shows the inhomogeneous enhancing metastases in the right temporal and parietal area.
Neuroendocrine tumors are the second most common pathologic type of laryngeal tumor, following only squamous cell carcinoma. Even so, they account for fewer than I % of all laryngeal neoplasms.I Among these epithelial tumors are poorly differentiated carcinoma (also called small-cell undifferentiated carcinoma), oat-cell carcinoma, and anaplastic small-cell carcinoma.' and more than 90% of patient s with these aggre ssive carcinomas develop met astatic disease .' In this article , we describ e an atypical case.
The patient was a 25-year-old, nonsmoking Hispanic wom an who presented with a 4-month history of gradually progressive hoar senes s. Endo scopic examination detected a small, fleshy tumor along the subglottic aspect of the left true vocal fold; no evidence of local or distant invasion was seen. Computed tomo graphy (CT) of the neck confirmed these findings (figure , A). The mass was locally resected . The lesion was pathologically and immunohistochemically consistent with a poorly differentiated carcinoma of neuroendocrine differenti ation . The patient underwent both radiation and chemotherapy with cisplat in and etoposide.
After 14 months without systemic sign s of disease, the patient was readmitted for evaluation of worsening headache s and lethargy. Imaging studies revealed widespread metastatic disease . CT and Tl -wei ghted magnetic resonance imaging (MRI ) of the head (figure , B) revealed the presen ce of two enhancing masses consistent with metastatic disease. T2-weighted MRI showed associated surrounding edem a and a moder ate mass effect. CT of the chest, abdomen, and pelvis identified numerous metastatic lesions. Surgical biop sy of the largest intracranial mass and bronchoscopic biopsy identified the masses as metastatic, undifferentiated neuroendocrine carcinomas ; they were strongly positi ve for cytokeratin and synaptophy sin. The patient had no obviou s evidence of recurrence of the primary laryngeal tumor. She underwent another course of chemotherapy. Her clinical cour se progressively deteriorated over the next 18 months, and she died. The most common sites of metastatic spread of poorly differenti ated or small-cell neuroendocrine carcinoma are the regional cervical lymph nodes , liver, lung , and bone. Only 8% of poorly differentiated neuroendocrine carc inomas of the larynx have been reported to metastasize to the central nervous system as a preterminal event .'
Most affected patients are men with a history of smoking. Appro ximately half of all patients have already developed a cervic al metastasis at the time of presentation, and approximately two-thirds die of widespread metastatic disease (survival range: I to 26 mo). 2 Because this tumor is believed to undergo early hematogenous spread , a metastatic workup is warranted . Therapy protocol s include a combination of radiation and chemoth erapy. Surgery is most effect ive when performed during the early stages of disea se and in patient s with no evidence of merastasis.P
The atypical aspect of this case is that our patient was a female nonsmoker with a relative ly small laryngeal tumor who developed late metastatic dissemination to the brain, lungs, and pelvis.
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